Jenn Powell sits with Ed Tobias, senior patient columnist at MS News Today. Diagnosed with MS at age 32 in 1980, Ed writes the “The MS Wire” column for Multiple Sclerosis News Today.
Join Jenn and Ed as they discuss living with secondary progressive MS later in life, disease-modifying-therapies, managing relationships, and more. Listen as Ed shares his broad spectrum of knowledge with the greater MS community.
A signaling protein called fractalkine helps to regulate the development of oligodendrocytes, cells of the nervous system responsible for making myelin — the protecting coating of nerve cell fibers that is damaged and lost in multiple sclerosis (MS). This finding was in the study “Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells,” published in Stem Cell […]
The U.S. Food and Drug Administration (FDA) has given the green light to a Phase 2 clinical trial that will assess the efficacy of using adult mesenchymal stem cells (MSCs) to treat the symptoms of mild to moderate multiple sclerosis (MS). The non-profit Hope Biosciences Stem Cell Research Foundation (HBSCRF), which received the FDA authorization, believes such stem […]
A signaling protein called fractalkine helps to regulate the development of oligodendrocytes, cells of the nervous system responsible for making myelin — the protecting coating of nerve cell fibers that is damaged and lost in multiple sclerosis (MS). This finding was in the study “Fractalkine signaling regulates oligodendroglial cell genesis from SVZ precursor cells,” published in Stem Cell […]
The U.S. Food and Drug Administration (FDA) has given the green light to a Phase 2 clinical trial that will assess the efficacy of using adult mesenchymal stem cells (MSCs) to treat the symptoms of mild to moderate multiple sclerosis (MS). The non-profit Hope Biosciences Stem Cell Research Foundation (HBSCRF), which received the FDA authorization, believes such stem […]
